SOURCE: Frost & Sullivan

March 09, 2011 01:30 ET

Wide Prevalence of Diseases Creates a Substantial Market for Clinical Diagnostics in East Africa, Finds Frost & Sullivan

CAPE TOWN, SOUTH AFRICA--(Marketwire - March 9, 2011) - The rising prevalence of diseases in East Africa has compelled governments and healthcare workers to focus on disease prevention rather than treatment, creating a vast market for clinical diagnostics. Accurate testing is needed for the early identification and mapping of diseases to control their spread and reduce treatment costs.

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), Clinical Diagnostics Industry in East Africa, finds that the market earned revenues of $80.7 million in 2009 and estimates these to reach $182.6 million in 2016.

East African countries are already on the World Health Organisation's (WHO's) list of 22 high-burden infectious disease-affected countries. According to the WHO, Africa accounts for 90 per cent of child mortality due to malaria and AIDS, and 50 per cent of all child mortality due to diarrhoeal disease and pneumonia. In addition, the continent has a quarter of the world's disease burden but only 3.0 percent of its healthcare workers, restricting the delivery of healthcare services.

"The region lacks skilled and trained laboratory personnel due to the low-quality of education and training imparted," says Frost & Sullivan Healthcare Research Analyst Sandhya Miseer. "Further, the trained staff is lured away by countries that pay higher salaries for the same responsibility."

Equipment donations by companies that do not provide the necessary training also limit product uptake in the clinical diagnostics industry.

Owing to this paucity of skilled personnel, there is considerable demand for high-quality, cost-effective and automated products. A rise in the number of communicable and non-communicable diseases in the region will further drive growth within the clinical diagnostics industry. Education and awareness will also increase the uptake of diagnostic tools.

"Investments and funding in East African countries are increasing, as investors are beginning to realise its market potential," notes the analyst. "Economic improvements allow the countries in the region to build and improve infrastructure and invest more money in their people which, in turn, will enhance healthcare delivery and services."

Clinical Diagnostics Industry in East Africa is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: The Medical Imaging Market in Tanzania, South African Advanced Wound Care Market, Strategic Analysis of the Healthcare Industry in Zambia and Overview of the Healthcare Industry in Namibia. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

If you are interested in more information on this study, please send an e-mail to Christie Cronje, Corporate Communications, at christie.cronje@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Clinical Diagnostics Industry in East Africa
M5D6